News-Medical publishes interview with Abselion on His-tagged protein analysisl
News-Medical has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, discussing how researchers are using the Amperia™ platform to support reliable His-tagged protein analysis across expression and early development workflows.
The feature highlights how Amperia’s RED-based detection, validated capture reagents and streamlined assay design enable fast and consistent measurements directly from crude lysates, helping teams reduce manual steps and maintain data quality as projects scale.
Read the full article here.